Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Barlas

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management|November 5, 2015
Interstate Compounding Plan Jars Hospitals: The Definitions of "Distribution" and "Inordinate" Stir ConcernStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|November 26, 2013
Proposed Changes in Medicare Hospital Payments Would Affect Pharmacy and Beyond: Drug Companies Push to Rein in 340B Discount DrugsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|March 10, 2016
Formulary Policies a Battleground In HHS Proposal on Nondiscrimination: Are Tiering and Cost Sharing Civil Rights Issues?Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|February 25, 2016
FDA Intensifies Drive to Reduce REMS Burdens: The Key Objective Is to Ease Workflow Obstacles for PharmacistsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|December 19, 2015
Pharmacists at Center of Drug Adherence Pilot: Medicare Is Finally Offering More Flexibility for MTM ProgramsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|April 13, 2016
Drug Companies and Physicians Push For Tighter P&T Committee Standards: Changes to NAIC Model Act Would Restrict Formularies, TooStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|September 16, 2016
Congress Enters Contentious Debate on Biosimilar Naming: Bill Provision Sides With Brand-Name Companies Over USPStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|September 6, 2019
Democratic Presidential Candidates Lead Attack on Drug Prices: Health Insurance Expansions Tougher on Drugs than Dems' Bill in HouseStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|August 10, 2016
Compounding Pharmacists Unhappy With New FDA Guidance Documents : Rules Severely Limit DistributionStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|July 18, 2018
Hospitals Search for IV Opioids: Has the DEA Been Fast and Flexible Enough?Stephen Barlas
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
P & T : a Peer-Reviewed Journal for Formulary Management|November 5, 2015
Interstate Compounding Plan Jars Hospitals: The Definitions of "Distribution" and "Inordinate" Stir ConcernStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|November 26, 2013
Proposed Changes in Medicare Hospital Payments Would Affect Pharmacy and Beyond: Drug Companies Push to Rein in 340B Discount DrugsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|March 10, 2016
Formulary Policies a Battleground In HHS Proposal on Nondiscrimination: Are Tiering and Cost Sharing Civil Rights Issues?Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|February 25, 2016
FDA Intensifies Drive to Reduce REMS Burdens: The Key Objective Is to Ease Workflow Obstacles for PharmacistsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|December 19, 2015
Pharmacists at Center of Drug Adherence Pilot: Medicare Is Finally Offering More Flexibility for MTM ProgramsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|April 13, 2016
Drug Companies and Physicians Push For Tighter P&T Committee Standards: Changes to NAIC Model Act Would Restrict Formularies, TooStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|September 16, 2016
Congress Enters Contentious Debate on Biosimilar Naming: Bill Provision Sides With Brand-Name Companies Over USPStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|September 6, 2019
Democratic Presidential Candidates Lead Attack on Drug Prices: Health Insurance Expansions Tougher on Drugs than Dems' Bill in HouseStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|August 10, 2016
Compounding Pharmacists Unhappy With New FDA Guidance Documents : Rules Severely Limit DistributionStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|July 18, 2018
Hospitals Search for IV Opioids: Has the DEA Been Fast and Flexible Enough?Stephen Barlas
Pageof 15